XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Cash, Cash Equivalents and Investments
9 Months Ended
Sep. 30, 2021
Cash, Cash Equivalents and Investments  
Cash, Cash Equivalents and Investments

Note 3 - Cash, Cash Equivalents and Investments

The following tables summarize our cash, cash equivalents, marketable securities, and held-to-maturity investments at September 30, 2021 and December 31, 2020 (in thousands):

As of September 30, 2021

    

    

Gross

    

Gross

    

  

  

Cash and

    

    

Amortized

Unrealized

Unrealized

Cash

Marketable

Short-Term

Long-Term

Cost

Gains

Losses

Fair Value

Equivalents

Securities

Investments

Investments

Cash

$

162,478

$

$

$

162,478

$

162,478

$

$

$

Level 1:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Money market funds

 

119,225

 

 

 

119,225

 

119,225

 

 

Agency bonds

 

48,000

 

49

 

 

48,049

 

 

40,000

 

8,000

Marketable securities

90,000

(6,660)

83,340

83,340

Subtotal

 

257,225

 

49

 

(6,660)

 

250,614

 

119,225

83,340

 

40,000

 

8,000

Level 2:

 

State and municipal obligations

 

77,764

4

(22)

77,746

72,383

5,381

Certificates of deposit

500

500

500

Corporate bonds

119,817

76

(95)

119,798

83,751

36,066

Commercial paper

 

19,994

19,994

19,994

Subtotal

 

218,075

80

(117)

218,038

176,628

41,447

Total

$

637,778

$

129

$

(6,777)

$

631,130

281,703

83,340

216,628

49,447

Expected credit loss reserve

(12)

(71)

(16)

Total, net of reserve for expected credit losses

$

281,691

$

83,340

$

216,557

$

49,431

During the quarter ended September 30, 2021, we acquired 9,000,000 shares of common stock of Cellebrite DI Ltd (“CLBT”) with a fair value of $90.0 million. The CLBT common stock is recorded as marketable securities in the accompanying condensed consolidated balance sheets and its fair value is adjusted every reporting period. Changes in fair value are recorded in the consolidated statement of operations as unrealized gain or (loss) on marketable securities, which is included in interest and other income (expense), net. During the three and nine months ended September 30, 2021, we recorded a $6.7 million unrealized loss on marketable securities relating to CLBT.

Because we do not have any history of losses for our held-to-maturity investments, our expected credit loss allowance methodology for held-to-maturity investments is developed using published or estimated credit default rates for similar investments and current and future economic and market conditions. At September 30, 2021 and December 31, 2020, our credit loss reserve for held-to-maturity investments was approximately $0.1 million and $0.2 million, respectively.

As of December 31, 2020

    

    

Gross

    

Gross

    

  

  

Cash and

    

    

Amortized

Unrealized

Unrealized

Cash

Short-Term

Long-Term

Cost

Gains

Losses

Fair Value

Equivalents

Investments

Investments

Cash

$

116,107

$

$

$

116,107

$

116,107

$

$

Level 1:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Money market funds

 

23,611

 

 

 

23,611

 

23,611

 

 

Agency bonds

 

63,794

 

122

 

 

63,916

 

 

23,794

 

40,000

Treasury Bills

96,384

6

96,390

96,384

Subtotal

 

183,789

 

128

 

 

183,917

 

23,611

 

120,178

 

40,000

Level 2:

State and municipal obligations

77,130

25

(28)

77,127

66,519

10,611

Certificates of deposit

500

500

500

Corporate bonds

212,825

232

(100)

212,957

2,525

170,205

40,095

U.S. Treasury repurchase agreements

13,200

13,200

13,200

Treasury inflation-protected securities

3,291

16

3,307

3,291

Commercial paper

45,974

45,974

45,974

Subtotal

352,920

273

(128)

353,065

15,725

286,489

50,706

Total

$

652,816

$

401

$

(128)

$

653,089

155,443

406,667

90,706

Expected credit loss reserve

(3)

(142)

(25)

Total, net of reserve for expected credit losses

$

155,440

$

406,525

$

90,681